These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 31945304

  • 1. The efficacy of gray matter atrophy and cognitive assessment in differentiation of aMCI and naMCI.
    Qin R, Li M, Luo R, Ye Q, Luo C, Chen H, Qian L, Zhu X, Bai F, Zhang B, Liu R, Zhao H, Xu Y.
    Appl Neuropsychol Adult; 2022; 29(1):83-89. PubMed ID: 31945304
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Gray matter atrophy patterns of mild cognitive impairment subtypes.
    Zhang H, Sachdev PS, Wen W, Kochan NA, Crawford JD, Brodaty H, Slavin MJ, Reppermund S, Draper B, Zhu W, Kang K, Trollor JN.
    J Neurol Sci; 2012 Apr 15; 315(1-2):26-32. PubMed ID: 22280946
    [Abstract] [Full Text] [Related]

  • 4. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J, Marecek R, Klobusiakova P, Balazova Z, Anderkova L, Nemcova-Elfmarkova N, Rektorova I.
    Brain Topogr; 2019 Jan 15; 32(1):142-160. PubMed ID: 30206799
    [Abstract] [Full Text] [Related]

  • 5. Structural Alteration of Medial Temporal Lobe Subfield in the Amnestic Mild Cognitive Impairment Stage of Alzheimer's Disease.
    He P, Qu H, Cai M, Liu W, Gu X, Ma Q.
    Neural Plast; 2022 Jan 15; 2022():8461235. PubMed ID: 35111220
    [Abstract] [Full Text] [Related]

  • 6. The Differentiation of Amnestic Type MCI from the Non-Amnestic Types by Structural MRI.
    Csukly G, Sirály E, Fodor Z, Horváth A, Salacz P, Hidasi Z, Csibri É, Rudas G, Szabó Á.
    Front Aging Neurosci; 2016 Jan 15; 8():52. PubMed ID: 27065855
    [Abstract] [Full Text] [Related]

  • 7. Cortical and subcortical gray matter abnormalities in mild cognitive impairment.
    Wang J, Liang X, Lu J, Zhang W, Chen Q, Li X, Chen J, Zhang X, Zhang B.
    Neuroscience; 2024 Oct 04; 557():81-88. PubMed ID: 39067683
    [Abstract] [Full Text] [Related]

  • 8. Brain metabolism and cerebrospinal fluid biomarkers profile of non-amnestic mild cognitive impairment in comparison to amnestic mild cognitive impairment and normal older subjects.
    Coutinho AM, Porto FH, Duran FL, Prando S, Ono CR, Feitosa EA, Spíndola L, de Oliveira MO, do Vale PH, Gomes HR, Nitrini R, Brucki SM, Buchpiguel CA.
    Alzheimers Res Ther; 2015 Sep 15; 7(1):58. PubMed ID: 26373380
    [Abstract] [Full Text] [Related]

  • 9. Divergent brain regional atrophy and associated fiber disruption in amnestic and non-amnestic MCI.
    Du C, Dang M, Chen K, Chen Y, Zhang Z.
    Alzheimers Res Ther; 2023 Nov 13; 15(1):199. PubMed ID: 37957768
    [Abstract] [Full Text] [Related]

  • 10. [A study of the correlation between gray matter atrophy in multiple sclerosis and impairment of cognitive function domains].
    Han J, Wang QJ, Wang CH, Li ZH, Bai RH, Zhang X, Liu JG.
    Zhonghua Nei Ke Za Zhi; 2024 Jul 01; 63(7):666-673. PubMed ID: 38951090
    [Abstract] [Full Text] [Related]

  • 11. Voxelwise Meta-Analysis of Gray Matter Abnormalities in Mild Cognitive Impairment and Subjective Cognitive Decline Using Activation Likelihood Estimation.
    Chen S, Xu W, Xue C, Hu G, Ma W, Qi W, Dong L, Lin X, Chen J.
    J Alzheimers Dis; 2020 Jul 01; 77(4):1495-1512. PubMed ID: 32925061
    [Abstract] [Full Text] [Related]

  • 12. Volumetric Assessment of Hippocampus and Subcortical Gray Matter Regions in Alzheimer Disease and Amnestic Mild Cognitive Impairment.
    Topkan TA, Erdogan N, Barutcu B, Cindil E, Tali ET, Karaman Y.
    Cogn Behav Neurol; 2022 Jun 01; 35(2):95-103. PubMed ID: 35639010
    [Abstract] [Full Text] [Related]

  • 13. Odor identification deficit in mild cognitive impairment and Alzheimer's disease is associated with hippocampal and deep gray matter atrophy.
    Hagemeier J, Woodward MR, Rafique UA, Amrutkar CV, Bergsland N, Dwyer MG, Benedict R, Zivadinov R, Szigeti K.
    Psychiatry Res Neuroimaging; 2016 Sep 30; 255():87-93. PubMed ID: 27567325
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Shared and specific dynamics of brain activity and connectivity in amnestic and nonamnestic mild cognitive impairment.
    Zhong X, Chen B, Hou L, Wang Q, Liu M, Yang M, Zhang M, Zhou H, Wu Z, Zhang S, Lin G, Ning Y.
    CNS Neurosci Ther; 2022 Dec 30; 28(12):2053-2065. PubMed ID: 35975454
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Baseline Frontoparietal Gray Matter Volume Predicts Executive Function Performance in Aging and Mild Cognitive Impairment at 24-Month Follow-Up.
    Lee AJ, Stark JH, Hayes SM, Alzheimer’s Disease Neuroimaging Initiative.
    J Alzheimers Dis; 2024 Dec 30; 100(1):357-374. PubMed ID: 38875035
    [Abstract] [Full Text] [Related]

  • 18. Differential and subtype-specific neuroimaging abnormalities in amnestic and nonamnestic mild cognitive impairment: A systematic review and meta-analysis.
    Yeung MK, Chau AK, Chiu JY, Shek JT, Leung JP, Wong TC.
    Ageing Res Rev; 2022 Sep 30; 80():101675. PubMed ID: 35724862
    [Abstract] [Full Text] [Related]

  • 19. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment.
    Noh SW, Han YH, Mun CW, Chung EJ, Kim EG, Ji KH, Seo JH, Kim SJ.
    J Neurol Sci; 2014 Dec 15; 347(1-2):210-3. PubMed ID: 25451006
    [Abstract] [Full Text] [Related]

  • 20. Are transversal MR images sufficient to distinguish persons with mild cognitive impairment from healthy controls?
    Mönninghoff C, Dlugaj M, Kraff O, Geisel MH, Jöckel KH, Erbel R, Weimar C, Wanke I, Heinz Nixdorf Recall Study Investigative Group.
    Acad Radiol; 2015 Sep 15; 22(9):1172-80. PubMed ID: 26162248
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.